FYI : The following is a concise update on Inova ownership and operations: News ReleaseTHU, 08 JUNE 2017Pacific Equity Partners and The Carlyle Group to jointly acquire iNova from Valeant2017-033SYDNEY Australia - Pacific Equity Partners and The Carlyle Group today announced that a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group has entered into a sale and purchase agreement with Valeant Pharmaceuticals International, Inc. to acquire the iNova Pharmaceuticals business for $930 million in cash. The transaction is subject to regulatory approvals.iNova markets a diversified portfolio of prescription and OTC products in areas such as weight management, pain management, cardiology and cough and cold and operates in more than 15 countries around the world. iNova holds leading market positions in Australia and South Africa and also has an established platform in Asia. Kens
NEU Price at posting:
$7.83 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)